Effects of Evobrutinib, a Bruton ' s Tyrosine Kinase Inhibitor, on Slowly Expanding Lesions: An Emerging Imaging Marker of Chronic Tissue Loss in Multiple Sclerosis

Authors
Category Primary study
JournalNeurology
Year 2022
This article has no abstract
Epistemonikos ID: 97986db30f66f8bf3cb5bb107c1d9e81808f997e
First added on: Feb 14, 2025